The Ministry of Health on Wednesday received a list of updated Healthcare Baskets for the coming year, which appears to include more drugs for diabetics but less for cancer patients.
The medical services basket is a list of government subsidies that includes the full range of services, drugs, medical equipment and appliances that members of the public are entitled to receive.
2 צפייה בגלריה
The chair of the healthcare basket panel said Dr. Shuki Shemer will present the panel’s recommendations for the year 2021 to Health Minister Yuli Edelstein
(Photo: Shalev Shalom)
After four months of deliberations, a panel of experts has submitted to Health Minister Yuli Edelstein and the Director General of the Ministry of Health Dr. Hezi Levy lists 117 drugs and technologies, including various medical treatments that serve more than 169,000 Israelis, at an estimated cost of NIS 550 million.
In total, the panel had received applications for approximately 880 different medicines and cures at a total cost of more than NIS 3 billion.
The latest drugs approved for diabetics include Trulicity, Bydureon, Victoza and Lixisenatide.
One panel member said that the expansion of treatments available for diabetics means they will be more accessible to more than half a million Israelis living with the condition.
“Until now, treatments for diabetes have been very limited. Many patients need them, but the basket has only given access to patients suffering from severe diabetes. , “he said.
“This is the most common illness in the country, and it has serious health consequences, and the basket has not been given proper treatment to date.”
Rexulti is the only approved drug in the field of mental health that is used to treat patients with schizophrenia.
The use of the emergency contraceptive drug Levonorgestrel (marketed in Israel under the brand name Postinor), which has so far been given only to victims of sexual assault, will now also bring its Introduce emergency contraception for women aged 20 and under.